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Conformationranes, such as ﬂuidity, charge or curvature inﬂuence their function. Proteins and
peptides can modulate those properties and conversely, the lipids can affect the activity and/or the structure
of the former. Tilted peptides are short hydrophobic protein fragments characterized by an asymmetric
distribution of their hydrophobic residues when helical. They were detected in viral fusion proteins and in
proteins involved in different biological processes that need membrane destabilization. Those peptides and
non lamellar lipids such as PE or PA appear to cooperate in the lipid destabilization process by enhancing the
formation of negatively-curved domains. Such highly bent lipidic structures could favour the formation of the
viral fusion pore intermediates or that of toroidal pores. Structural ﬂexibility appears as another crucial
property for the interaction of peptides with membranes. Computational analysis on another kind of lipid-
interacting peptides, i.e. cell penetrating peptides (CPP) suggests that peptides being conformationally
polymorphic should be more prone to traverse the bilayer. Future investigations on the structural intrinsic
properties of tilted peptides and the inﬂuence of CPP on the bilayer organization using the techniques
described in this chapter should help to further understand the molecular determinants of the peptide/lipid
inter-relationships.
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Physical properties ofmembranes, such asﬂuidity, charge or curvature
inﬂuence their function. Proteins and peptides can modulate those
properties and conversely, the hydrophobic environment and lipid/
protein (peptide) interactions can affect their activity and/or their




MS, root mean square; TFE,
81622522.
l rights reserved.effects on reconstituted lipid systems. Since years, our lab has been
developing “in silico” approaches to better understand the molecular
determinants of peptide (or protein)/lipid interactions and their mutual
effects.
On one hand, modifying the lamellar organization of the lipids and
hence the membrane stability could lead to processes such as fusion
or formation of membrane pores. The ﬁrst part of this chapter will
focus on the effects of tilted peptides on the membrane organization
related to the peptide properties. Tilted peptides are short protein
fragments characterized by an asymmetric distribution of hydro-
phobic residues, allowing an oblique insertion into the membrane.
We will decipher how they could cooperate with lipids to favour
fusion or pore formation.
On the other hand, some intrinsic factors of peptides, such as the
hydrophobicity or the charge inﬂuence peptide/lipid interactions, and
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the aqueous environment. Structural ﬂexibility should also be a key
parameter in the interaction between peptides and lipids. Recent
studies on the conformation of viral tilted peptides reveal that class I
viral FPs show structural ﬂexibility and that they vary between helical
and irregular secondary structures [1]. Structural ﬂexibility should
also be one of the main features of carrier peptides, such as cell
penetrating peptides (CPP). The latter ensure the delivery of non-
penetratingmolecules across membranes in a conservativeway. In the
second part of the chapter, we present how molecular modelling
approaches allow studying the relationship between structural
properties of peptides and their lipid permeability.
2. Tilted peptides and membrane organization
Many important biological processes involve the partitioning of
protein fragments into lipid membranes. Such peptides are typically
quite hydrophobic. In 1988, we have predicted that the fusion peptide
(FP) of the Newcastle Disease Virus (NDV) adopts an angle of 55° in a
DPPC monolayer when helical, suggesting for the ﬁrst time a tilted
orientation of a peptide in the membrane [2]. Later, other viral FPs
were also predicted by our group and by others as having a tilted
membrane insertion. Those peptides come fromviruses such as the SIV
[3], HIV-1, HA2 [4,5], BLV [6], Ebola [5,7],… This peculiar orientation
was conﬁrmed by different experimental approaches notably by in-
frared spectroscopy, allowing the determination of the relative
orientation of the HIV-1 [8], SIV [9] and HA2 [10] FPs towards lipid
membranes. Neutron diffraction studies have conﬁrmed the orienta-
tion of the SIV FP in model membranes [11], and EPR and NMR ap-Fig. 1. Representation of tilted peptides (C) as compared to transmembrane (B) or amph
isopotentials, and green surfaces the hydrophilic ones. Below, the peptide is oriented in a sc
(mauve) is the PL acyl chain/headgroup interface; second upper plane (pink) is the PL headproaches have determined the structure and tilted orientation of the
HA2 FP in DPC micelles [12]. Recent studies have also underlined the
importance of the tilted conﬁguration for the fusogenic activity [13].
Oblique-oriented peptides were also detected in proteins other
than viral fusogenic domains, notably in proteins involved in lipid
metabolism [5,14,15], in neurotoxic proteins [5,16–19] or in different
biological processes involving membrane destabilization [20,21].
Recently, a “de novo” fusogenic peptide made of nonnatural amino
acids was successfully designed, based on its ability to insert obliquely
in a membrane [22]. It indicates that this peculiar membrane insertion
is not speciﬁc to fragments from biological proteins and is a crucial
feature for membrane destabilization. Since all those peptides adopt a
tilted orientation towards the membrane, they were called “tilted
peptides”. All those fragments show no or little sequence identity, but
possess some common features. They all are relatively hydrophobic,
contain a high amount of small residues and importantly, display a
gradient of hydrophobic amino acids along their axis when helical
[5,23–25]. They are not only amphipathic (hydrophobic on one side,
less hydrophobic on the other side), but also their net hydrophobicity
increases from one end of the helix to the other (Fig. 1). Because of this
hydrophobic asymmetry, they orient with an angle around 50° when
they are at a hydrophobic/hydrophilic interface, such as the lipid/water
interface [23]. It should be noted that when they are β-conformed, this
gradient is no more present [23,26].
Experimentally,most of thepeptides predicted as tiltedbymolecular
modelling induce fusion and leakage of liposomes [15,17,18,27], sug-
gesting that they destabilize the lipid organization. Relation between
tiltedness and fusion or more generally lipid destabilization has been
highlighted experimentally. We have notably recently shown that theipathic peptides (A). In the upper view, orange surfaces represent the hydrophobic
hematic symmetric membrane: the yellow plane is the bilayer centre; the upper plane
group/water interface.
Fig. 2. Assembly between the SIV peptide (in CPK representation) and DPPE molecules. The white line indicates the tilt of the acyl chains induced by the peptide and the effect on the
lipid curvature.
1539L. Lins et al. / Biochimica et Biophysica Acta 1778 (2008) 1537–1544fusogenicity of the FP of different glycoproteins from enveloped viruses,
such as gp41 from HIV (Human Immunodeﬁciency Virus) [28], gp30
from BLV (Bovine Leukemia Virus) [29] or gp 32 from SIV (Simian Im-
munodeﬁciency Virus) [30], is related to its oblique lipid insertion.
It should be noted that the destabilizing potency of the peptides is
not simply related to their mean hydrophobicity. Actually, mutations of
different tilted peptides (such as those from the viral fusion protein of
SIV and Ebola, from apo C-III and apo A-II, both involved in the lipid
metabolism, or from two neurotoxic proteins) have been designed in silico
tomodify the distribution of the hydrophobic residues, while keeping the
same mean hydrophobicity of the WT peptide. All the mutants show a
decreased lipid-destabilizing activity [6,7,9,15,17,18,27,31]. Furthermore,
restoring tiltedness by introducing new mutations restores the fusogeni-
city of the mutants [15,31].
To further investigate the effects of tilted peptides and especially
the SIV tilted peptide, on lipids, we used different computational
approaches. One of them allows assembling a central molecule (here
the peptide) with lipids and to analyze the effects of the former on the
lipidmonolayer organization [32]. Brieﬂy, the position of the peptide is
frozen and the lipid molecule is moved along and around the peptide
(rotations, tilts and translations). For each position, the energy of
interaction is calculated and is stored in a matrix. The position of the
ﬁrst lipid corresponds to the lowest energy complex; a second mo-
lecule is positioned as the next energetically favourable position in the
matrix, taking into account the presence of the ﬁrst lipid. For the next
lipids, the same process is repeated until the peptide is completely
surrounded with lipids. Fig. 2 shows that a negative curvature is ob-
tainedwhenphosphatidylethanolamine (PE) is assembledwith the SIV
peptide. This effect is less pronounced with phosphatidylcholine.
Experimentally, lipid-mixing of liposomes made of PC (phospha-
tidylcholine), SM (sphingomyelin) and cholesterol with or without PE
was followed by measuring the ﬂuorescence increase of R18, a lipid
soluble probe, occurring after the fusion of labelled and unlabelled
lipid particles [33]. The fusion observed in the presence of PE suggests
a cooperative effect between this lipid and the peptide (Fig. 3). This
inter-dependency was also mentioned for other viral FPs, like the
feline leukemia virus FP, since the rate of fusion is correlated to the
presence of non lamellar lipids [34,35].
The same conclusions were drawn from 31P and 2H NMR ex-
periments for other tilted peptides in the presence of PE. It has been
shown that the fusogenic effects of the peptide were related to the
appearance of non-bilayer structures, disorganizing the lipids [36].The effects of the SIV peptide in the absence or in the presence of
non lamellar lipids have also been investigated by AFM techniques. In
collaboration with the lab of Y. Dufrêne (CIFA, UCL, Belgium), we have
shown that the presence of small amounts of phosphatidic acid (PA)
plays a key role inmodulating the interaction of the peptidewithDOPC
(dioleylphosphatidylcholine)/DPPC (dipalmitoylphosphatidylcholine)
bilayers [37]. The incubation of the lipids with the SIV peptide pro-
voked the appearance of elevated domains or nanorods at the interface
between the DOPC and depressed DPPC phases in the presence of 0.5%
mol PA (Fig. 4A). With time, the elevated domains slowly desorbed
from the supported bilayer. These nanorods were presumably pro-
duced by the self-association of reverse cylindersmade of peptides and
lipids, due to the exposure of lipid tails; their association hence de-
creases the contact with the aqueous medium. This is schematically
represented on Fig. 4B. It is important to note that a non-tilted peptide
such as an amphipathic helix did not induce the samemodiﬁcations of
the lipid organization [37,38].
The cooperative effects of tilted peptides and non lamellar lipids
were further supported by the study of the activity of piracetam, a
nootropic agent, on lipid fusion. We have shown that this drug is able
to reduce the destabilizing effects induced by tilted peptides, when
pre-incubated with liposomes [39]. This effect is assumed to be due to
a stabilization of the bilayer structure by interaction of piracetamwith
phospholipids and especially with PE, as shown by conformational
analysis [39]. Themechanism is supposed to be that, while the peptide
induces lipid disorganization and a negative curvature (as that shown
on Fig. 2), piracetam coats the phospholipid headgroups. Due to its
inverted cone shape, it makes the formation of negatively-curved lipid
domains energetically less favourable.
The presence of negatively-curving lipids alone is often not sufﬁcient
to induce fusion; the insertion of tilted peptides could induce initial
destabilization. The AFM pictures have clearly demonstrated that non
lamellar lipids are important to promote themodiﬁcationsofmembrane
structure by tilted peptides [37,38]. For the viral tilted peptides, they
could help the formation of structures closely related to a toroidal pore,
as suggested in the process ofmembrane fusion induced by viruses such
as HA2 [40,41], or help the formation of highly bent lipidic structures,
like the stalks or transmonolayer contacts (TMC) involved in the for-
mation of the fusion pore [42].
It is important to note that other tilted peptides such as the hy-
drophobic C-terminal helices of the pore-forming domain of colicin
E1 also induced the samemodiﬁcations of the lipid system, as observed
Fig. 3. Fusogenic effects of the SIV peptide dissolved in TFE at 150 µM on liposomes (small unilamellar vesicles) composed of PC/SM/Chol (■) or PC/PE/SM/Chol (●), corresponding to a
peptide/lipid molar ratio of 1/10. In these assays, the peptide is added to a mixture (1:4 w/w ratio) of R18-labelled and unlabelled SUV's and R18 ﬂuorescence is followed at room
temperature during 15 min. The contribution of TFE (1.6% ﬁnal concentration) is substracted from the curves.
1540 L. Lins et al. / Biochimica et Biophysica Acta 1778 (2008) 1537–1544by AFM [43]. Colicins arewater-soluble bacterial proteins that insert in
membranes through conformational changes. They are composed of
three domains among which the C-terminal domain, also called the
pore-forming (pf) domain, is responsible for the lipid insertion. WeFig. 4. A. Elevated domains induced by the SIV peptide in DOPC/DPPC/DOPA (495:500:5
mol:mol ratio) bilayers as observed by AFM. B. Schematic representation of the effect of
the SIV peptide on DOPC/DPPC/DOPA bilayers. The peptide, at high concentration, could
induce the formation of local depressions probably due to PL interdigitation and/or
ﬂuidization. After a while, the depressed domains should slowly evolve to protruding
structures presumably composed of metastable cylindrical reverse micelles. These
micelles are thought to associate due to their hydrophobicity and give rise to the
nanorods observed on the AFM images. The nanorods then desorb from the lipid surface
(not shown). Adapted from Lins et al., 2007 [43].have shown that the hydrophobic hairpin lying in the core of the
soluble form of the pf domain, is formed by two helices that have the
properties of tilted peptides[43]. We have suggested that the tilted
fragments of ColE1 are able to destabilize the membrane and thus to
facilitate the insertion of the whole pf domain. Channel formationwas
proposed to occur via a toroidal pore [44,45]. This model supports a
direct implication of lipids in the formation of the pore. It was notably
demonstrated that lipids promoting negative curvature increase
transiently and in the initial steps, the efﬁciency of pore formation
[44]. Since tilted peptides are thought to promote negative curvature,
this is in agreement with our hypothesis that the tilted peptides of
colicin E1 help pore formation and notably insertion, i.e. in the ﬁrst
steps of the process. Stabilization should notably occur through the
presence of positive curvature inducers (such as lysophosphatidylcho-
line) [44].
It is alsoworth to note that apoptotic proteins from the Bcl-2 family,
such as Bax, could form a toroidal pore [46,47]. These proteins have a
conformation close to that of the pf domain of colicins (notably by the
presence of a hydrophobic hairpin), and they are able to switch from a
water-soluble form to a lipid-inserted conﬁguration. The hydrophobic
helices were shown to induce pores [48–50]. We have recently
suggested that the hydrophobic hairpin of Bax contains a tilted peptide
[20], that could play the same role in initiating the pore formation.Table 1
Sequences of wild type and variant peptides with their experimental internalization
capacity (3rd column) (from ref [49] and [48]) and Peplook predicted polymorphism
(M = monomorphic and P = polymorphic) (4th column)
Peptide Sequence Internalization Peplook
Penetratin RQIKIWFQNRRMKWKK + + + P
Penetratin 48 RQIKIFFQNRRMKWKK + M
Penetratin 48–56 RQIKIFFQNRRMKFKK − M
Transportan GWTLNSAGYLLGKINLKALAALAKKIL + + + P
TP07 - - - LNSAGYLLGKINLKALAALAKKIL + + + P
TP08 - - - - - - - - - LLGKINLKALAALAKKIL −/+ M
TP10 - - - - - - AGYLLGKINLKALAALAKKIL + + + P
TP13 - - - LNSAGYLLG- - - -KALAALAKKIL −/+ M
TP15 - - - LNSAGYLLGK- -LKALAALAK- - - −/+ M
1541L. Lins et al. / Biochimica et Biophysica Acta 1778 (2008) 1537–1544It should be noted that all tilted peptides are not thought to be
involved in toroidal pore formation and all peptides that are descri-
bed as making such structures, like lytic amphipathic peptides (for
example, megainin[51], mellitin [52],…), are not necessarily tilted
peptides.
3. Structural plasticity and membrane properties of peptides
Small peptides can generally adopt various conformations in
solution. In the case of FPs, structure has been shown to vary between
random, extended and helical structures, even for the same peptide in
various conditions. For instance, the FP from the HIV-1 gp41 fusion
protein has been shown to be helical [8,53–55], extended [56–64] or
even a combination of both structures [65–69] in function of
techniques and the experimental conditions. The structure(s) relevant
for fusion in a biological context is still under debate. The ﬂexibility of
the FP and the dynamics of the fusion process make this much more
difﬁcult to unravel. For other FPs like the one from Inﬂuenza A, results
are less divergent. Hence, the FP from Inﬂuenza A HA2 that has been
shown to adopt a ﬁxed-angle boomerang structure with helicalFig. 5. left: Representation of themost energetically favorable structure of each structural popul
environment (red for the Prime and blue, white and green for the different subpopulations); rig
different subpopulations in a hydrophobic environment and blue curves in a hydrophilic mediu
deviation while the N-terminal moiety is polymorphic. TP13 is fully helical and monomorphic.portions (reviewed in [70]). Recently, Weise and Reed reported a
systematic structural analysis of FPs from different viruses (Inﬂuenza
A, HIV-1, RSV, TBEV, and VSV) studied by CD spectroscopy in similar
conditions [1]. Their results reveal that class I viral FPs show a
structural ﬂexibility and that they vary between helical and irregular
secondary structures.
Structural ﬂexibility should also be one of the main features of
carrier peptides, such as cell penetrating peptides (CPP). The latter
ensure the delivery of non-penetrating molecules across membranes
in a conservative way [71–73]. CPPs are generally used according two
main strategies. The covalent approach implies the formation of
a chemical link between the carrier and the cargo. This strategy is
applied to peptides such as TAT48-60, the basic fragment of the
transcription activating factor from HIV-1[74], Penetratin, a 16 amino
acids segment derived from the Antennapedia homeodomain of Dro-
sophila melanogaster [75], or Transportan, a chimeric 27 residues pep-
tide built from the N-terminal fragment of the neuropeptide galanine
and the wasp venom mastoparan linked by a lysine [76]. The non-
covalent strategy consists in the formation of a carrier/cargo parti-
cle stabilized by intermolecular non-covalent interactions. Severalation for transportan (TP-panel A) and twomutants, TP10 (B) and TP13 (C) in a hydrophobic
ht: mean RMSd [win_9] (in Å) as a function of the sequence. Red curves correspond to the
m. The C-terminal moiety of the structural families of TP and TP10 presents no structural
Adapted from Deshayes et al., 2008 [91].
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developed for a non-covalent use.
Despite the numerous studies carried out in order to understand
the translocation process and hence the peptide/membrane interac-
tions, the mechanism remains unclear and controversial even if
various models were suggested. Among them reverse micelle model
[80], local electroporation [81], transient pore-like structure [82], in-
duced-membrane fusion [83], endocytotic pathways [84–86] or a
combination of several models [87] are described. Some of these
peptides are self-permeant, irrespective of any cargo andwe examined
this property.
Carrier peptides share some common features: their sequence does
not exceed 30 residues, they are amphipathic and have a positive net
charge. Charges are important for the formation of a complex with
charged cargoes like DNAs, for the interaction with the polar heads of
the lipids but also to ensure the solubility of the carrier/cargo complex.
The amphipathicity is important for the interactionwith themembrane
and with the cargo. It was also shown that the structure as well as
the environment effect on conformation of a carrier peptide might be
important for the internalization abilities [88–90].
Very recently, we suggested that the structural polymorphism of a
peptide could be, as well as its amphipathicity or its net charge, a
parameter required for its self-cellular uptake and hence its interac-
tion with lipids [91]. The hypothesis is that, if a peptide must be
soluble in different environments like water and membrane, it must
be able to adapt its apparent hydrophobicity by modulating its
conformation. Of course that does not exclude speciﬁc mechanisms of
permeability such as endocytosis that were also described.
To analyze the intrinsic polymorphism of carriers, we used the
newly developed PepLook method [92]. This method is a Boltzmann-
stochastic algorithm that explores the 3D conformational space of a
peptide by an iterative calculation process using couples of phi/psi
angles derived from the work of Etchebest et al [93]. The only input is
the peptide primary sequence. After calculation, PepLook provides the
most stable 3D structure, namely the Prime and 99 next low energy 3D
models.
Twowell-known covalent carrier peptides and their mutants were
analyzed by Peplook [94]. These mutants were described to be
permeant (so-called positive) or non-permeant (so-called negative).
The molecules were Penetratin, Penetratin W48F andW48/56F on the
one hand [95] and Transportan, TP07, TP08, TP10, TP13 and TP15 on
the other hand (Table 1).
Polymorphism of the 99 PepLook models of a peptide was scored.
The score was derived from the ﬁtting of molecules on the Prime and
the analysis of the RMSd (RMS deviation on a 9-residues window).
This score allows to evaluate the structural diversity (monomorphic
vs. polymorphic), to map it in sequence, and thus to cluster the 99
models into homogeneous subpopulations.
The “in silico” study demonstrated that Penetratin W48F, Pene-
tratin W48/56F, TP08, TP13 and TP15 which exhibit a weak or no
internalization capacity, present no structural variation, i.e. they are
monomorphic. On the contrary, the wild type peptides and the
positive variants TP07 and TP10 which are experimentally taken up by
cells are all polymorphic. As an example, on Fig. 5, both Transportan
(Fig. 5A) and TP10 (Fig. 5B) two permeant CPPs, are polymorphic, and
are clustered into three and two distinct structural populations,
respectively. In those peptides, the C-terminal moiety remains helical
whereas the N-terminal moiety is variable. The peptide TP13 that is
not taken up by cells is helical and monomorphic, displaying a single
structural population (Fig. 5C).
We thus suggest that the conformational polymorphism of
peptides is an important parameter for membrane permeability, in
addition to other properties such as the charge, the amphipathicity or
the length. This structural feature should be related to the fact that, to
be soluble in different solvents, a peptide must be able to modify itsconformation to adapt its apparent hydrophobicity to the medium, i.e.
membrane or water.
4. Conclusions
Combining computational and experimental approaches, we have
underlined the mutual effects existing between peptides and lipids
interacting together.
On one hand, tilted peptides and non lamellar lipids, such as PE
or PA, are thought to have a cooperative action in the lipid des-
tabilization process inwhich the peptides are involved. It is clear from
the different approaches that the interaction of the peptides with
lipids inducing a negative curvature increases the effects of the latter
on the membrane curvature. This underlines the inter-relationship
between the lipid properties and the activity of those peculiar peptides
on the membrane.
The second part of the chapter shows how the intrinsic properties of
peptides can inﬂuence their interaction with the membrane. Peptides
being structurally polymorphic appear more prone to traverse the lipid
bilayer. This feature should be related to the fact that they have to
interactwith different environments (lipids, water and the interfaces in-
between) and hence to adapt their conformation.
Future investigations on the structural intrinsic properties of tilted
peptides and the inﬂuence of cell penetrating peptides on the bilayer
organization by the same techniques should help to further under-
stand the molecular determinants of the peptide/lipid inter-
relationships.
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